01 (Image 01)
Nifedipine Tablet, Extended Release
Product Images NDC 71335-1550
4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 71335-1550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
02 (Image 02)
A data table comparing the percentage incidence of adverse effects in subjects treated with Nifedipine extended-release tablets at 30 mg versus placebo. The table lists headache, fatigue, dizziness, constipation, and nausea with corresponding percentage values for each group.*
03 (Image 03)
A data table presenting adverse effects comparing Nifedipine capsules and placebo groups. It lists various side effects such as dizziness, headache, and flushing, along with their reported percentages in each group (N=226 for Nifedipine, N=235 for placebo). The table quantifies the frequency of each adverse effect in the two cohorts.*
Label Image (Lbl713351550)
Packaging label for Nifedipine ER 30 mg extended-release tablets by Bryant Ranch Prepack. The label includes comparison information to Procardia XL 30 mg tablets and mentions Ingenus Pharmaceuticals LLC. It indicates storage instructions to keep in a light-resistant container at room temperature (20°-25°C). The label displays the product NDC as 71335-1550 and shows a barcode with lot number 142437.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
